It was found that syphilis-kodecytes used in blood grouping platforms are capable of the same sensitivity and specificity as validated assays. The ability to engineer the FSL construct and replace the functional peptide for other infectious markers allows for a highly flexible and rapid-development technique for the detection of antibody-defined infectious markers and may be an important low-technology tool for use in epidemics and pandemics, particularly in third-world environments.
The sensitivity of the FSL-SYPH3 kodecytes in the Capture microplate assay (Method 1) was found to be better than the Capture S method which uses modified VDRL antigen bound to the microplates (Table1). FSL-SYPH3 kodecytes, when used in blood typing anti-IgG gel cards (Method 2), produced good reactions (figure 3) and was found to be more sensitive than RPR (rapid plasma reagin) and TPHA (treponemal pallidum hemagglutination assay) syphilis assays and detected 96 of 98 (98%) of EIA+TPPA (enzyme immuno assay + treponemal pallidum particle agglutination) validated positive samples ( Using a series of algorithms to predict biological activity three candidate FSL-syphilis constructs were synthesised. Two of these FSLs showed no biological activity but one, FSL-SYPH3 (figure 1) showed activity against syphilis positive samples. Two methods based on established microplate and gel card serological methods were established.
: FSL-SYPH3 kodecytes were created Method 1 was evaluated in parallel with the Capture S method on a against panels of validated positive and negative samples. The negative panel was 32 syphilis serology negative donor plasma samples. The positive panel was 5 Syphilis Qualification Panel samples obtained from SeraCare Life Sciences and confirmed positive using the Olympus PK TP system, plus 20 Syphilis Validation Panel samples from Plasma Services Group, Inc. These samples were confirmed positive using the Arlington Scientific RPR and EuroimmunTP IgG and IgM ELISA assays.
SYPH3-kodecytes were created as above except Serology was in Diamed anti-IgG LISS gel cards and used as per instructions. Method 2 was evaluated in parallel against 98 syphilis-positive clinical patient samples which were confirmed as positive by both TPPA & EIA.
Method 1 -FSL-SYP3 Capture
Method 2 -FSL-SYPH3 gelcard:
by incubating 40% packed blood group O red cells with an equal volume of a solution containing (10µg/ml) FSL-SYPH3 and incubation overnight at @ 4°C, followed by washing. Modification was confirmed by flow cytometry (figure 2). SYPH3-kodecytes were captured onto microplates, dried and used essentially as described .
Galileo automated blood bank instrument incubation was for 2 hours @ 37°C.
Materials & Methods
The ability to detect infectious agents is a prerequisite to the treatment and containment of transmittable diseases. Many diagnostics assays are based upon the detection of antibodies in serum against the infectious agent and often rely on ELISA or agglutination-based assays to determine the infectious status. Using function-spacer-lipid (FSL) constructs bearing peptides representative of an infectious agent attached to human red cells, offers a potential alternative diagnostic approach to the detection of antibody-defined infections. Using the syphilis spirochaete as a model, and a peptide selection algorithm, a series of FSL constructs were created and attached to human red cells creating syphilis-kodecytes. These kodecytes were then tested in routine blood typing platforms against serum from panels and blood donors of known syphilis status. This approach has already been successfully used to detect ethnic-specific blood group antibodies .
1-3 4 4 FSL constructs are analogous in structure to a flower and consist of three components; a unctional head group (like the flower head), a pacer (like a stalk) and a diacyl ipid tail (the anchoring roots). All FSLs are biocompatible and allow users to introduce novel unctional moieties to the membrane surface of living cells. 
